HHLR ADVISORS, LTD.
13F Holdings and Portfolio Analysis
Zhang Lei 2021 Q4 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
HHLR ADVISORS, LTD. Overview
HHLR ADVISORS, LTD. held 76 stocks in 2021 Q4, with total market value around $6.47B.
HHLR ADVISORS, LTD.'s top five holdings in 2021 Q4: BeOne Medicines AG(ONC) 22.91%, On Holding AG(ONON) 9.33%, Legend Biotech Corporation(LEGN) 8.50%, Salesforce, Inc.(CRM) 7.58%, NOVABRIDGE BIOSCIENCES(NBP) 5.26%.
- Portfolio Value
- $6.47B
- Current Holdings
- 76 stocks
- New / Increased
- 3 / 8
- Reduced / Exited
- 7 / 12
Current Holdings
| 1 | BeOne Medicines AGONC | 1.48 | 22.91% | 5.47 - | $270.93 | $316.42 +16.79% | $136.90 | 0.00 | 3.25 | +$0.98B+131.14% | Held |
| 2 | On Holding AGONON | 0.60 | 9.33% | 15.97 - | $37.81 | $41.82 +10.61% | $30.13 | 0.00 | 0.50 | +$0.19B+38.80% | Held |
| 3 | Legend Biotech CorporationLEGN | 0.55 | 8.50% | 11.80 +6.78% | $46.61 | $31.96 -31.43% | $49.87 | +0.75 | 1.75 | -$0.21B-35.91% | Increased |
| 4 | Salesforce, Inc.CRM | 0.49 | 7.58% | 1.93 +53.88% | $254.13 | $210.90 -17.01% | $215.06 | +0.68 | 2.00 | -$0.01B-1.93% | Increased |
| 5 | NOVABRIDGE BIOSCIENCESNBP | 0.34 | 5.26% | 7.18 - | $47.39 | - | $50.06 | 0.00 | 1.50 | -$0.02B-5.34% | Held |
| 6 | JD.com, Inc.JD | 0.33 | 5.16% | 4.77 - | $70.07 | $33.07 -52.80% | $59.29 | 0.00 | 3.25 | -$0.13B-44.22% | Held |
| 7 | Sea LimitedSE | 0.28 | 4.28% | 1.24 +275.09% | $223.71 | $90.53 -59.53% | $79.68 | +0.91 | 0.50 | +$0.01B+13.61% | Increased |
| 8 | DoorDash, Inc.DASH | 0.19 | 2.98% | 1.30 +8.36% | $148.90 | $154.61 +3.83% | $143.84 | +0.10 | 1.25 | +$0.01B+7.49% | Increased |
| 9 | iQIYI, Inc.IQ | 0.18 | 2.72% | 38.65 - | $4.56 | $2.03 -55.48% | $18.04 | 0.00 | 3.25 | -$0.62B-88.75% | Held |
| 10 | Li Auto Inc.LI | 0.16 | 2.48% | 5.01 +363.64% | $32.10 | $22.51 -29.88% | $30.85 | +3.93 | 0.50 | -$0.04B-27.03% | Increased |
| 11 | Cytek Biosciences, Inc.CTKB | 0.14 | 2.21% | 8.76 - | $16.32 | $3.95 -75.80% | $21.41 | 0.00 | 0.50 | -$0.15B-81.55% | Held |
| 12 | Mondelez International, Inc.MDLZ | 0.12 | 1.91% | 1.86 - | $66.31 | $62.41 -5.88% | $40.03 | 0.00 | 3.25 | +$0.04B+55.91% | Held |
| 13 | ENFUSION INCENFN | 0.10 | 1.61% | 4.98 | $20.94 | - | $20.94 | +4.98 | 0.25 | $0.00B0.00% | New |
| 14 | KE Holdings Inc.BEKE | 0.10 | 1.56% | 5.01 - | $20.12 | $18.29 -9.10% | $61.29 | 0.00 | 1.50 | -$0.22B-70.16% | Held |
| 15 | BridgeBio Pharma, Inc.BBIO | 0.09 | 1.38% | 5.36 - | $16.68 | $54.92 +229.26% | $20.26 | 0.00 | 2.75 | +$0.19B+171.13% | Held |
| 16 | Yatsen Holding LimitedYSG | 0.09 | 1.34% | 40.45 +16031.39% | $2.15 | $8.42 +291.63% | $2.24 | +40.20 | 1.25 | +$0.25B+275.54% | Increased |
| 17 | Gossamer Bio, Inc.GOSS | 0.08 | 1.30% | 7.42 - | $11.31 | $2.19 -80.64% | $16.64 | 0.00 | 3.00 | -$0.11B-86.84% | Held |
| 18 | Vipshop Holdings LimitedVIPS | 0.08 | 1.16% | 8.96 - | $8.40 | $14.22 +69.28% | $1.49 | 0.00 | 1.00 | +$0.11B+852.44% | Held |
| 19 | Erasca, Inc.ERAS | 0.07 | 1.14% | 4.72 - | $15.58 | $2.42 -84.47% | $21.22 | 0.00 | 0.50 | -$0.09B-88.60% | Held |
| 20 | Coupang, Inc.CPNG | 0.07 | 1.10% | 2.43 +11.23% | $29.38 | $16.68 -43.23% | $28.00 | +0.24 | 0.50 | -$0.03B-40.44% | Increased |
| 21 | Playtika Holding Corp.PLTK | 0.06 | 0.88% | 3.28 - | $17.29 | $3.52 -79.64% | $27.21 | 0.00 | 1.00 | -$0.08B-87.06% | Held |
| 22 | Affiliated Managers Group, Inc.AMG | 0.06 | 0.85% | 0.34 - | $164.51 | $235.60 +43.21% | $28.12 | 0.00 | 2.25 | +$0.07B+737.75% | Held |
| 23 | Amazon.com, Inc.AMZN | 0.05 | 0.77% | 0.01 | $3334.33 | $264.24 -92.08% | $3334.33 | +0.01 | 0.25 | -$0.05B-92.08% | New |
| 24 | Uber Technologies, Inc.UBER | 0.05 | 0.72% | 1.11 - | $41.93 | $73.03 +74.17% | $29.85 | 0.00 | 2.50 | +$0.05B+144.64% | Held |
| 25 | TAIWAN SEMICONDUCTOR MFG LTDTSM | 0.04 | 0.67% | 0.36 - | $120.31 | $439.48 +265.29% | $56.77 | 0.00 | 1.75 | +$0.14B+674.14% | Held |
Showing 1-25 of 76
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2021 Q4.
| 1 | Beam Therapeutics Inc.BEAM | 1.45 | 1.75 | $18.00 | $87.01 | +$0.10B+383.39% |
| 2 | Alibaba Group Holding LimitedBABA | 0.71 | 0.75 | $226.77 | $118.79 | -$0.08B-47.62% |
| 3 | Illumina, Inc.ILMN | 0.17 | 0.25 | $405.61 | $405.61 | $0.00B0.00% |
| 4 | Bilibili Inc.BILI | 0.64 | 3.00 | $30.91 | $46.40 | +$0.01B+50.10% |
| 5 | Lyell Immunopharma, Inc.LYEL | 2.35 | 0.50 | $16.24 | $14.80 | -$0.00B-8.87% |
| 6 | Pacific Biosciences of California, Inc.PACB | 0.91 | 0.25 | $25.55 | $25.55 | $0.00B0.00% |
| 7 | Keurig Dr Pepper Inc.KDP | 0.28 | 1.50 | $30.41 | $34.16 | +$0.00B+12.33% |
| 8 | Advanced Micro Devices, Inc.AMD | 0.07 | 0.25 | $102.90 | $102.90 | $0.00B0.00% |
| 9 | KRONOS BIO INCKRON | 0.15 | 1.00 | $29.87 | $20.96 | -$0.00B-29.82% |
| 10 | COVETRUS INCCVET | 0.16 | 1.75 | $8.14 | $18.14 | +$0.00B+122.80% |
| 11 | CODIAK BIOSCIENCES INCCDAK | 0.14 | 1.00 | $32.30 | $16.33 | -$0.00B-49.44% |
| 12 | CCC INTELLIGENT SOLUTIONS HLCCCS | 0.04 | 0.25 | $2.33 | $2.33 | $0.00B0.00% |
Showing 1-12 of 12
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.